Biological rationale for the design of polymeric anti-cancer nanomedicines

Y Zhou, J Kopeček - Journal of drug targeting, 2013 - Taylor & Francis
Understanding the biological features of cancer is the basis for designing efficient anti-
cancer nanomedicines. On one hand, important therapeutic targets for anti-cancer …

Anti-CD20 multivalent HPMA copolymer-Fab′ conjugates for the direct induction of apoptosis

TW Chu, J Yang, J Kopeček - Biomaterials, 2012 - Elsevier
A hybrid biomimetic system comprising high-molecular-weight, linear copolymer of N-(2-
hydroxypropyl) methacrylamide (HPMA) grafted with multiple Fab′ fragments of anti-CD20 …

HPMA-based polymeric conjugates in anticancer therapeutics

S Rani, U Gupta - Drug discovery today, 2020 - Elsevier
Highlights•HPMA (N-2-hydroxypropylmethacrylamide) is an emerging polymeric alternative
for drug delivery applications.•HPMA can be potentially conjugated to develop copolymers …

N-(2-hydroxypropyl) methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging

J Fang, V Šubr, W Islam, S Hackbarth, R Islam… - European Journal of …, 2018 - Elsevier
Tumor-targeted photodynamic therapy (PDT) using polymeric photosensitizers is a
promising therapeutic strategy for cancer treatment. In this study, we synthesized a pHPMA …

SET-LRP of N-(2-hydroxypropyl) methacrylamide in H 2 O

NH Nguyen, C Rodriguez-Emmenegger, E Brynda… - Polymer …, 2013 - pubs.rsc.org
SET-LRP of N-(2-hydroxypropyl)methacrylamide in H 2 O - Polymer Chemistry (RSC
Publishing) DOI:10.1039/C3PY00220A Royal Society of Chemistry View PDF VersionPrevious …

Hybrid polymeric hydrogels via peptide nucleic acid (PNA)/DNA complexation

TW Chu, J Feng, J Yang, J Kopeček - Journal of Controlled Release, 2015 - Elsevier
This work presents a new concept in hybrid hydrogel design. Synthetic water-soluble N-(2-
hydroxypropyl) methacrylamide (HPMA) polymers grafted with multiple peptide nucleic acids …

[HTML][HTML] A two-step pretargeted nanotherapy for CD20 crosslinking may achieve superior anti-lymphoma efficacy to rituximab

TW Chu, R Zhang, J Yang, MP Chao, PJ Shami… - Theranostics, 2015 - ncbi.nlm.nih.gov
The use of rituximab, an anti-CD20 mAb, in combination with chemotherapy is the current
standard for the treatment of B-cell lymphomas. However, because of a significant number of …

Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry

M Talelli, K Morita, CJF Rijcken, RWM Aben… - Bioconjugate …, 2011 - ACS Publications
Doxorubicin is an anthracycline anticancer agent that is commonly used in the treatment of a
variety of cancers, but its application is associated with severe side effects. Biodegradable …

Macromolecular HPMA-based nanoparticles with cholesterol for solid-tumor targeting: detailed study of the inner structure of a highly efficient drug delivery system

SK Filippov, P Chytil, PV Konarev… - …, 2012 - ACS Publications
We report a rigorous investigation into the detailed structure of nanoparticles already shown
to be successful drug delivery nanocarriers. The basic structure of the drug conjugates …

Low temperature aqueous living/controlled (RAFT) polymerization of carboxybetaine methacrylamide up to high molecular weights

C Rodriguez‐Emmenegger… - Macromolecular …, 2011 - Wiley Online Library
Among the class of zwitterionic polymers poly (carboxybetaine) s (poly (CB) s) are unique,
emerging as the only ultra‐low fouling materials known allowing the preparation of …